Antonio E. Muruato

7.6k total citations · 2 hit papers
31 papers, 2.5k citations indexed

About

Antonio E. Muruato is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Antonio E. Muruato has authored 31 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 21 papers in Public Health, Environmental and Occupational Health and 8 papers in Epidemiology. Recurrent topics in Antonio E. Muruato's work include Mosquito-borne diseases and control (21 papers), Viral Infections and Vectors (18 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Antonio E. Muruato is often cited by papers focused on Mosquito-borne diseases and control (21 papers), Viral Infections and Vectors (18 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Antonio E. Muruato collaborates with scholars based in United States, Brazil and China. Antonio E. Muruato's co-authors include Pei‐Yong Shi, Xuping Xie, Scott C. Weaver, Shannan L. Rossi, Chao Shan, Jing Zou, Vineet D. Menachery, Robert B. Tesh, Camila R. Fontes-Garfias and Sasha R. Azar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Antonio E. Muruato

30 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of a Novel Murine Model to Study Zika Virus

2016 363 citations Shannan L. Rossi, Sasha R. Azar et al. profile →
An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction

2018 227 citations Hongjie Xia, Huanle Luo et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio E. Muruato United States	20	2.1k	1.5k	608	299	290	31	2.5k
Jing Zou United States	32	2.9k 1.4×	1.6k 1.1×	459 0.8×	331 1.1×	622 2.1×	67	3.6k
Etienne Simon‐Lorière France	30	1.9k 0.9×	1.1k 0.7×	539 0.9×	194 0.6×	740 2.6×	67	3.1k
James Weger‐Lucarelli United States	27	1.6k 0.8×	1.8k 1.2×	354 0.6×	537 1.8×	258 0.9×	79	2.4k
Daniel Watterson Australia	27	1.3k 0.6×	1.2k 0.8×	356 0.6×	319 1.1×	318 1.1×	86	2.1k
Flávia Barreto dos Santos Brazil	27	2.1k 1.0×	2.8k 1.9×	519 0.9×	233 0.8×	168 0.6×	109	3.2k
Chunya Puttikhunt Thailand	24	1.9k 0.9×	2.3k 1.5×	274 0.5×	317 1.1×	309 1.1×	59	2.8k
Kai Dallmeier Belgium	23	1.5k 0.7×	747 0.5×	396 0.7×	132 0.4×	296 1.0×	72	2.2k
Joseph E. Blaney United States	29	1.8k 0.9×	1.8k 1.2×	607 1.0×	290 1.0×	374 1.3×	48	2.7k
Tomohiko Takasaki Japan	39	3.3k 1.6×	3.8k 2.5×	546 0.9×	461 1.5×	355 1.2×	191	4.8k
Wanwisa Dejnirattisai United Kingdom	21	2.9k 1.4×	3.3k 2.2×	666 1.1×	344 1.2×	315 1.1×	27	3.9k

Countries citing papers authored by Antonio E. Muruato

Since Specialization

Citations

This map shows the geographic impact of Antonio E. Muruato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio E. Muruato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio E. Muruato more than expected).

Fields of papers citing papers by Antonio E. Muruato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio E. Muruato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio E. Muruato. The network helps show where Antonio E. Muruato may publish in the future.

Co-authorship network of co-authors of Antonio E. Muruato

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio E. Muruato. A scholar is included among the top collaborators of Antonio E. Muruato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio E. Muruato. Antonio E. Muruato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tisoncik-Go, Jennifer, Thomas B. Lewis, Antonio E. Muruato, et al.. (2023). Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina. SHILAP Revista de lepidopterología. 3. 2 indexed citations

Liu, Yang, Xianwen Zhang, Jianying Liu, et al.. (2022). A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nature Communications. 13(1). 4337–4337. 62 indexed citations

Newhouse, Daniel, Antonio E. Muruato, Sarah Edwards, et al.. (2022). ZIKV can infect human term placentas in the absence of maternal factors. Communications Biology. 5(1). 243–243. 7 indexed citations

Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2021). Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 12(1). 3984–3984.

Xie, Xuping, Kumari G. Lokugamage, Xianwen Zhang, et al.. (2021). Engineering SARS-CoV-2 using a reverse genetic system. Nature Protocols. 16(3). 1761–1784. 106 indexed citations

Muruato, Antonio E., Camila R. Fontes-Garfias, Ping Ren, et al.. (2021). Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nature Communications. 12(1). 4000–4000. 1 indexed citations

Muruato, Antonio E., Michelle N. Vu, Bryan A. Johnson, et al.. (2021). Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge. PLoS Biology. 19(11). e3001284–e3001284. 44 indexed citations

Adam, Awadalkareem, Camila R. Fontes-Garfias, Vanessa V. Sarathy, et al.. (2021). A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission. npj Vaccines. 6(1). 27–27. 7 indexed citations

Muruato, Antonio E., Camila R. Fontes-Garfias, Ping Ren, et al.. (2020). A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nature Communications. 11(1). 4059–4059. 207 indexed citations

10.

Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2020). A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 11(1). 142 indexed citations

11.

Shan, Chao, Hongjie Xia, Sherry L. Haller, et al.. (2020). A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission. Proceedings of the National Academy of Sciences. 117(33). 20190–20197. 51 indexed citations

12.

Xie, Xuping, et al.. (2020). Using recombination-dependent lethal mutations to stabilize reporter flaviviruses for rapid serodiagnosis and drug discovery. EBioMedicine. 57. 102838–102838. 20 indexed citations

13.

Xie, Xuping, Antonio E. Muruato, Kumari G. Lokugamage, et al.. (2020). An Infectious cDNA Clone of SARS-CoV-2. Cell Host & Microbe. 27(5). 841–848.e3. 348 indexed citations

14.

Xie, Xuping, et al.. (2020). Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test. Diagnostic Microbiology and Infectious Disease. 99(2). 115248–115248. 14 indexed citations

15.

Shan, Chao, Xuping Xie, Huanle Luo, et al.. (2019). Maternal vaccination and protective immunity against Zika virus vertical transmission. Nature Communications. 10(1). 5677–5677. 30 indexed citations

16.

Xie, Xuping, Dieudonné Buh Kum, Hongjie Xia, et al.. (2018). A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission. Cell Host & Microbe. 24(4). 487–499.e5. 42 indexed citations

17.

Xie, Xuping, Yujiao Yang, Antonio E. Muruato, et al.. (2017). Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis. mBio. 8(1). 69 indexed citations

18.

Fontes-Garfias, Camila R., Chao Shan, Huanle Luo, et al.. (2017). Functional Analysis of Glycosylation of Zika Virus Envelope Protein. Cell Reports. 21(5). 1180–1190. 122 indexed citations

19.

Yang, Yujiao, Chao Shan, Jing Zou, et al.. (2017). A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine. EBioMedicine. 17. 145–156. 34 indexed citations

20.

Langsjoen, Rose M., Tiffany F. Kautz, Albert J. Auguste, et al.. (2016). Molecular Virologic and Clinical Characteristics of a Chikungunya Fever Outbreak in La Romana, Dominican Republic, 2014. PLoS neglected tropical diseases. 10(12). e0005189–e0005189. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact